CIGARETTE SMOKING AND THE RISK OF BARRETT’S ESOPHAGUS: A SYSTEMATIC REVIEW AND META-ANALYSIS (#300)
12:00 PM
META-ANALYSIS: ORAL BISPHOSPHONATES AND THE RISK OF OESOPHAGEAL CANCER (#301)
12:00 PM
HOT FOOD AND BEVERAGE CONSUMPTION AND THE RISK OF ESOPHAGEAL CANCER: A META-ANALYSIS (#302)
12:00 PM
microRNA expression in Barrett’s oesophagus mucosa from patients treated with medical vs. surgical anti-reflux therapy (#303)
12:00 PM
Reconstitution of both squamous and Barrett’s epithelium from BAR-T cells – support for a common cell of origin. (#304)
12:00 PM
Characterisation and validation of a new oesophageal adenocarcinoma cell line (#305)
12:00 PM
DNA copy number variations of a novel gene JS-1 in colorectal adenocarcinomas (#306)
12:00 PM
VEGF expression in colorectal tumours with microsatellite instability and its association with BRAF mutation status (#307)
12:00 PM
Mutagen-induced aberrant crypt foci formation in mouse colon is increased in response to prior inflammation. (#308)
12:00 PM
The cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett’s oesophagus with or without biomarker testing (#309)
12:00 PM
DETERMINATION OF BIOMARKERS OF COLON CANCER STEM CELLS (#310)
12:00 PM
Improved Engraftment of Oesophageal Patient-Derived Tumour Xenografts Using a Novel Intramuscular Technique. (#311)
12:00 PM
Outcomes of Salvage Oesophagectomy following Definitive Chemoradiotherapy – A Systematic Review and Analysis. (#312)
12:00 PM
EFFECT OF ESTROGEN ON GROWTH AND APOPTOSIS IN ESOPHAGEAL ADENOCARCINOMA CELLS (#313)
12:00 PM
Next Generation Sequencing of Multiple Families with Familial Barrett’s Oesophagus (#314)
12:00 PM
Identification of biomarkers of chemoradiotherapy-induced toxicity in upper gastrointestinal cancers (#315)
12:00 PM
Origins of Barrett’s Esophagus: Targeting Stem Cells in Precursors of Cancers (#316)
12:00 PM